Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">Score</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">APACHE II ≤ 21.5</td><td class="align_center">0</td></tr><tr><td class="align_left">APACHE II &gt; 21.5</td><td class="align_center">1</td></tr><tr><td class="align_left">Gal-3-T72 ≤ 7.165</td><td class="align_center">0</td></tr><tr><td class="align_left">Gal-3-T72 &gt; 7.165</td><td class="align_center">1</td></tr><tr><td class="align_left">BNP-T72 ≤ 4461.5</td><td class="align_center">0</td></tr><tr><td class="align_left">BNP-T72 &gt; 4461.5</td><td class="align_center">1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Death early warning rating table.</div>

Cardiology Research and Practice

tab5

Table 5

Table 5: Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients 